Compare Stocks: AMIX, VVOS, NDRA, and PAVM

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$19.50 +434.2%	$6.68	$2.44 ▼ $32.55	$1.98M	-1.17	4.78 million shs	118.56 million shs
NDRA ENDRA Life Sciences	$4.22 +1.0%	$4.94	$2.96 ▼ $9.85	$5.31M	-0.05	29,968 shs	12,481 shs
PAVM PAVmed	$5.04 -8.4%	$5.36	$3.85 ▼ $28.44	$5.48M	0.54	11,638 shs	10,224 shs
VVOS Vivos Therapeutics	$0.46 +9.9%	$0.51	$0.36 ▼ $5.12	$5.84M	6.22	151,780 shs	33.64 million shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	+6.10%	+30.82%	-43.23%	-54.13%	-87.50%
NDRA ENDRA Life Sciences	-11.77%	-12.97%	-11.86%	-15.02%	-14.05%
PAVM PAVmed	+11.11%	+5.77%	-3.68%	-31.68%	-65.11%
VVOS Vivos Therapeutics	+2.59%	+4.37%	-7.19%	-40.72%	-91.88%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$19.50 +434.2%	$6.68	$2.44 ▼ $32.55	$1.98M	-1.17	4.78 million shs	118.56 million shs
NDRA ENDRA Life Sciences	$4.22 +1.0%	$4.94	$2.96 ▼ $9.85	$5.31M	-0.05	29,968 shs	12,481 shs
PAVM PAVmed	$5.04 -8.4%	$5.36	$3.85 ▼ $28.44	$5.48M	0.54	11,638 shs	10,224 shs
VVOS Vivos Therapeutics	$0.46 +9.9%	$0.51	$0.36 ▼ $5.12	$5.84M	6.22	151,780 shs	33.64 million shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	+6.10%	+30.82%	-43.23%	-54.13%	-87.50%
NDRA ENDRA Life Sciences	-11.77%	-12.97%	-11.86%	-15.02%	-14.05%
PAVM PAVmed	+11.11%	+5.77%	-3.68%	-31.68%	-65.11%
VVOS Vivos Therapeutics	+2.59%	+4.37%	-7.19%	-40.72%	-91.88%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	2.00	Hold	$42.00	115.38% Upside
NDRA ENDRA Life Sciences	2.00	Hold	$25.00	492.42% Upside
PAVM PAVmed	2.00	Hold	$56.00	1,011.11% Upside
VVOS Vivos Therapeutics	2.25	Hold	$2.80	505.80% Upside

Current Analyst Ratings Breakdown

Latest AMIX, VVOS, NDRA, and PAVM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/28/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
7/17/2026	NDRA ENDRA Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	PAVM PAVmed	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
7/17/2026	VVOS Vivos Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/10/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
6/23/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
6/8/2026	PAVM PAVmed	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$65.00 ➝ $56.00
6/4/2026	VVOS Vivos Therapeutics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$3.00 ➝ $3.10
6/3/2026	AMIX Autonomix Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
6/2/2026	AMIX Autonomix Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold

(Data available from 8/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$10.85 per share	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	$1.92 per share	N/A
PAVM PAVmed	$70K	72.00	N/A	N/A	($2.42) per share	-2.08
VVOS Vivos Therapeutics	$17.44M	0.37	N/A	N/A	($0.16) per share	-2.89

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$16.72M	-$74.58	N/A	N/A	N/A	N/A	-239.36%	-192.46%	8/12/2026 (Estimated)
NDRA ENDRA Life Sciences	-$7.03M	-$8.15	N/A	N/A	N/A	N/A	-433.64%	-204.58%	8/13/2026 (Estimated)
PAVM PAVmed	$400K	-$37.40	N/A	N/A	N/A	-21,914.12%	-146.19%	-18.39%	8/14/2026 (Estimated)
VVOS Vivos Therapeutics	-$21.17M	-$2.14	N/A	N/A	N/A	-127.70%	-2,325.64%	-98.12%	8/18/2026 (Estimated)

Latest AMIX, VVOS, NDRA, and PAVM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2026	Q2 2026	VVOS Vivos Therapeutics	-$0.42	N/A	N/A	N/A	$5.63 million	N/A
8/14/2026	Q2 2026	PAVM PAVmed	-$0.63	N/A	N/A	N/A	$0.05 million	N/A
8/13/2026	Q2 2026	NDRA ENDRA Life Sciences	-$0.84	N/A	N/A	N/A	$0.10 million	N/A
8/12/2026	Q1 2027	AMIX Autonomix Medical	-$6.4050	N/A	N/A	N/A	N/A	N/A
5/20/2026	Q1 2026	VVOS Vivos Therapeutics	-$0.45	-$0.52	-$0.07	-$0.52	$4.35 million	$5.14 million
5/15/2026	Q1 2026	NDRA ENDRA Life Sciences	-$1.23	-$1.09	+$0.14	-$1.09	N/A	N/A
5/14/2026	Q1 2026	PAVM PAVmed	-$0.69	-$1.17	-$0.48	-$4.42	$0.07 million	$0.02 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	N/A
PAVM PAVmed	N/A	N/A	N/A	N/A	N/A
VVOS Vivos Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	4.45	4.45
NDRA ENDRA Life Sciences	N/A	0.64	0.64
PAVM PAVmed	0.70	2.02	2.02
VVOS Vivos Therapeutics	N/A	0.27	0.27

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
NDRA ENDRA Life Sciences	1.19%
PAVM PAVmed	19.93%
VVOS Vivos Therapeutics	26.35%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	6.20%
NDRA ENDRA Life Sciences	10.00%
PAVM PAVmed	13.40%
VVOS Vivos Therapeutics	2.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	1	540,000	509,000	N/A
NDRA ENDRA Life Sciences	20	1.27 million	1.14 million	Not Optionable
PAVM PAVmed	90	1.00 million	863,000	No Data
VVOS Vivos Therapeutics	160	13.90 million	13.60 million	Optionable

AMIX, VVOS, NDRA, and PAVM Headlines

Recent News About These Companies

Vivos Therapeutics (VVOS) Stock Fair Value Falls After Analyst Target Cuts

July 18, 2026 | finance.yahoo.com

Vivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth Assumptions

July 3, 2026 | finance.yahoo.com

Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants

June 30, 2026 | markets.businessinsider.com

Vivos' Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants

June 30, 2026 | globenewswire.com

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

June 22, 2026 | globenewswire.com

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

June 11, 2026 | globenewswire.com

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to ...

June 10, 2026 | markets.businessinsider.com

Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

June 10, 2026 | globenewswire.com

Vivos Therapeutics, Inc. to Present at The Small Cap Showcase & WTR Insights on June 9, 2026

June 8, 2026 | quiverquant.comQ

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

June 8, 2026 | globenewswire.com

Vivos Therapeutics Announces Debt Exchange Agreement with Streeterville Capital to Strengthen Financial Position

June 5, 2026 | quiverquant.comQ

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

June 5, 2026 | globenewswire.com

Vivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic Shifts

May 29, 2026 | finance.yahoo.com

Vivos Therapeutics Balances Rapid Growth With Cash Strain

May 22, 2026 | tipranks.com

Vivos Therapeutics Earnings Call: Growth Meets Cash Strain

May 21, 2026 | tipranks.com

Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

May 21, 2026 | finanznachrichten.de

Vivos Therapeutics, Inc. (VVOS) Q1 2026 Earnings Call Transcript

May 21, 2026 | seekingalpha.com

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

May 20, 2026 | globenewswire.com

Vivos Therapeutics Delays Quarterly Filing

May 15, 2026 | tipranks.com

Analysts see 200%+ upside in these 3 high-risk stocks: here's why?

May 9, 2026 | invezz.comI

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX, VVOS, NDRA, and PAVM Company Descriptions

Autonomix Medical NASDAQ:AMIX

$19.50 +15.85 (+434.25%)

Closing price 04:00 PM Eastern

Extended Trading

$14.70 -4.80 (-24.63%)

As of 08:00 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

ENDRA Life Sciences NASDAQ:NDRA

$4.22 +0.04 (+0.96%)

Closing price 04:00 PM Eastern

Extended Trading

$4.30 +0.08 (+1.87%)

As of 05:09 PM Eastern

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

PAVmed NASDAQ:PAVM

$5.04 -0.46 (-8.36%)

Closing price 04:00 PM Eastern

Extended Trading

$5.01 -0.03 (-0.50%)

As of 07:34 PM Eastern

PAVmed Inc. focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck. Its product pipeline also comprises EsoCure EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Vivos Therapeutics NASDAQ:VVOS

$0.46 +0.04 (+9.89%)

Closing price 04:00 PM Eastern

Extended Trading

$0.32 -0.14 (-29.68%)

As of 07:59 PM Eastern

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMIX, VVOS, NDRA, and PAVM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMIX, VVOS, NDRA, and PAVM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMIX, VVOS, NDRA, and PAVM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX, VVOS, NDRA, and PAVM Company Descriptions

Autonomix Medical NASDAQ:AMIX

ENDRA Life Sciences NASDAQ:NDRA

PAVmed NASDAQ:PAVM

Vivos Therapeutics NASDAQ:VVOS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AMIX, VVOS, NDRA, and PAVM Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AMIX, VVOS, NDRA, and PAVM Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AMIX, VVOS, NDRA, and PAVM Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMIX, VVOS, NDRA, and PAVM Company Descriptions

Autonomix Medical NASDAQ:AMIX

ENDRA Life Sciences NASDAQ:NDRA

PAVmed NASDAQ:PAVM

Vivos Therapeutics NASDAQ:VVOS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools